137 related articles for article (PubMed ID: 34286808)
1. An ether-linked halogenated phenazine-quinone prodrug model for antibacterial applications.
Huigens Iii RW; Yang H; Liu K; Kim YS; Jin S
Org Biomol Chem; 2021 Aug; 19(30):6603-6608. PubMed ID: 34286808
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of Carbonate-Linked Halogenated Phenazine-Quinone Prodrugs with Improved Water-Solubility and Potent Antibacterial Profiles.
Xiao T; Liu K; Gao Q; Chen M; Kim YS; Jin S; Ding Y; Huigens RW
ACS Infect Dis; 2023 Apr; 9(4):899-915. PubMed ID: 36867688
[TBL] [Abstract][Full Text] [Related]
3. Modular Synthetic Routes to Fluorine-Containing Halogenated Phenazine and Acridine Agents That Induce Rapid Iron Starvation in Methicillin-Resistant
Liu K; Brivio M; Xiao T; Norwood VM; Kim YS; Jin S; Papagni A; Vaghi L; Huigens RW
ACS Infect Dis; 2022 Feb; 8(2):280-295. PubMed ID: 35089005
[TBL] [Abstract][Full Text] [Related]
4. Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.
Xiao T; Liu K; Huigens RW
Bioorg Med Chem Lett; 2020 Nov; 30(22):127515. PubMed ID: 32860978
[TBL] [Abstract][Full Text] [Related]
5. A Modular Synthetic Route Involving
Yang H; Kundra S; Chojnacki M; Liu K; Fuse MA; Abouelhassan Y; Kallifidas D; Zhang P; Huang G; Jin S; Ding Y; Luesch H; Rohde KH; Dunman PM; Lemos JA; Huigens RW
J Med Chem; 2021 Jun; 64(11):7275-7295. PubMed ID: 33881312
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of halogenated phenazine antibacterial prodrugs targeting nitroreductase enzymes for activation.
Liu K; Xiao T; Yang H; Chen M; Gao Q; Brummel BR; Ding Y; Huigens RW
RSC Med Chem; 2023 Aug; 14(8):1472-1481. PubMed ID: 37593580
[TBL] [Abstract][Full Text] [Related]
7. An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
Garrison AT; Abouelhassan Y; Kallifidas D; Tan H; Kim YS; Jin S; Luesch H; Huigens RW
J Med Chem; 2018 May; 61(9):3962-3983. PubMed ID: 29638121
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications.
Yang H; Liu K; Jin S; Huigens Iii RW
Org Biomol Chem; 2021 Feb; 19(7):1483-1487. PubMed ID: 33521803
[TBL] [Abstract][Full Text] [Related]
9. Halogenated Phenazines that Potently Eradicate Biofilms, MRSA Persister Cells in Non-Biofilm Cultures, and Mycobacterium tuberculosis.
Garrison AT; Abouelhassan Y; Kallifidas D; Bai F; Ukhanova M; Mai V; Jin S; Luesch H; Huigens RW
Angew Chem Int Ed Engl; 2015 Dec; 54(49):14819-23. PubMed ID: 26480852
[TBL] [Abstract][Full Text] [Related]
10. Starving Bacteria of Iron: A Potential Strategy to Disperse Bacterial Biofilms.
Naclerio GA; Sintim HO
J Med Chem; 2021 Jun; 64(11):7272-7274. PubMed ID: 33988992
[TBL] [Abstract][Full Text] [Related]
11. Transcript Profiling of MRSA Biofilms Treated with a Halogenated Phenazine Eradicating Agent: A Platform for Defining Cellular Targets and Pathways Critical to Biofilm Survival.
Abouelhassan Y; Zhang Y; Jin S; Huigens RW
Angew Chem Int Ed Engl; 2018 Nov; 57(47):15523-15528. PubMed ID: 30230671
[TBL] [Abstract][Full Text] [Related]
12. A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis.
Yang H; Abouelhassan Y; Burch GM; Kallifidas D; Huang G; Yousaf H; Jin S; Luesch H; Huigens RW
Sci Rep; 2017 May; 7(1):2003. PubMed ID: 28515440
[TBL] [Abstract][Full Text] [Related]
13. Synthetically Tuning the 2-Position of Halogenated Quinolines: Optimizing Antibacterial and Biofilm Eradication Activities via Alkylation and Reductive Amination Pathways.
Basak A; Abouelhassan Y; Norwood VM; Bai F; Nguyen MT; Jin S; Huigens RW
Chemistry; 2016 Jun; 22(27):9181-9. PubMed ID: 27245927
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Resistance to Phenazine Antibiotics in
Fu T; Cai Z; Yue Z; Yang H; Fang B; Zhang X; Fan Z; Pan X; Yang F; Jin Y; Cheng Z; Wu W; Sun B; Huigens RW; Yang L; Bai F
ACS Infect Dis; 2021 Mar; 7(3):636-649. PubMed ID: 33650853
[TBL] [Abstract][Full Text] [Related]
15. The Path to New Halogenated Quinolines With Enhanced Activities Against
Huigens RW
Microbiol Insights; 2018; 11():1178636118808532. PubMed ID: 30397386
[TBL] [Abstract][Full Text] [Related]
16. Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis.
Borrero NV; Bai F; Perez C; Duong BQ; Rocca JR; Jin S; Huigens RW
Org Biomol Chem; 2014 Feb; 12(6):881-6. PubMed ID: 24389824
[TBL] [Abstract][Full Text] [Related]
17. The sponges Hymeniacidon perlevis and Halichondria panicea are reservoirs of antibiotic-producing bacteria against multi-drug resistant Staphylococcus aureus.
Rodriguez Jimenez A; Dechamps E; Giaux A; Goetghebuer L; Bauwens M; Willenz P; Flahaut S; Laport MS; George IF
J Appl Microbiol; 2021 Aug; 131(2):706-718. PubMed ID: 33421270
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
20. A Phytochemical-Halogenated Quinoline Combination Therapy Strategy for the Treatment of Pathogenic Bacteria.
Abouelhassan Y; Garrison AT; Bai F; Norwood VM; Nguyen MT; Jin S; Huigens RW
ChemMedChem; 2015 Jul; 10(7):1157-62. PubMed ID: 25982664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
